Company
Belluscura PLC
LON:BELL
Belluscura PLC is a leading medical device developer focused on lightweight and portable oxygen enrichment technology. The company either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments. Belluscura's first product, the X-PLO₂R, is a lightweight FDA cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices.
16 stories
Belluscura remains confident despite big jump in half-year losses
"I am very pleased with the substantial operational progress the group has made since the launch of our first product in September last year,” said CEO Bob Rauker
Archive
eEnergy unveils partnership for electric vehicle charging points
A look at the major movers on the London market on Wednesday
Archive
Small Cap Wrap - Sabien Technology, Netscientific, Lexington Gold and more...
The gold exploration and development company with projects in North and South Carolina, USA, updated with respect to its latest ongoing 5,000m Reverse Circulation drilling programme. Drill campaign commenced at Carolina Belle on 18 October
Belluscura hails strong investor support as debuts on AIM
The company raised a net £16.1mln on a market capitalisation of just under £51mln